CXCL1 and squamous cell carcinoma: The third ELR+ chemokine under investigation, CXCL1, originally identified as melanoma growth stimulating activity, has recently been adressed a role in HIV-infection [27] and correlated with tumorigenic and angiogenic effects and metastasis in squamous cell carcinoma and melanoma [28,29].